Biolase, Inc. (BIOLQ) vs Holdco Nuvo Group D.G Ltd. (NUVOQ)

Biolase, Inc. and Holdco Nuvo Group D.G Ltd. are both Medical Devices companies. Biolase, Inc. and Holdco Nuvo Group D.G Ltd. are of similar size ($2.3M and $2.1M). Holdco Nuvo Group D.G Ltd. has the higher net margin (0.00% vs −71.8%) and the higher return on invested capital (0.00% vs −109.5%). Across the 10 metrics below, Biolase, Inc. leads on 5 and Holdco Nuvo Group D.G Ltd. on 5.

Valuation

Metric BIOLQ NUVOQ Medical Devices median
P/E n/m n/m 22.18
P/S n/m n/m 2.70
P/B n/m n/m 2.46
Price to free cash flow n/m n/m 22.53
EV/EBITDA n/m n/m 11.78
EV/Sales 0.28 n/m 2.38
Earnings yield 0.00% 0.00% (8.22%)
Free cash flow yield 0.00% 0.00% (7.80%)

Profitability

Metric BIOLQ NUVOQ Medical Devices median
Gross margin 34.44% — 56.01%
Operating margin (29.37%) 0.00% (15.03%)
Net margin (71.75%) 0.00% (20.40%)
Free cash flow margin (28.55%) 0.00% (7.24%)
Return on equity 1,349.30% 63.38% (15.32%)
Return on assets (100.09%) (930.47%) (19.72%)
Return on invested capital (109.48%) 0.00% (10.33%)

Growth

Metric BIOLQ NUVOQ Medical Devices median
Revenue growth (TTM) (7.44%) — 8.80%
EPS growth (last fiscal year) 92.92% (53.51%) —
Revenue growth, 5-year CAGR 1.27% — 15.23%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric BIOLQ NUVOQ Medical Devices median
Debt to equity (3.29) (0.17) 0.07
Current ratio 0.63 0.05 2.50
Net debt to EBITDA (0.51) (0.67) 0.49

Dividend

Metric BIOLQ NUVOQ Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric BIOLQ NUVOQ Medical Devices median
Market cap 2.33m 2.12m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack